...Acad. Sci. USA; published online Nov. 12, 2020doi:10.1073/pnas.2012939117CONTACT: Matthew B. Frieman, University of Maryland School of Medicine, Baltimore, Md.email: mfrieman@som.umaryland.edu Claire Quang University of Maryland Infectious Coronavirus Influenza...

...hearing about how vaccine developers are measuring efficacy, citing a Sept. 22 op-ed in The New York Times by Scripps Research’s Eric Topol and University of Maryland’s Peter...

...researcher Larry Corey, and Kathleen Neuzil, director of the Center for Vaccine Development at the University of Maryland...

...partnered with the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) and the University of Maryland...

...and partnering with United States Army Medical Research Institute of Infectious Diseases (USAMRIID) and the University of Maryland...

...Maryland team highlights 17 approved drugs that could be repurposed for COVID-19 A University of Maryland team identified...
...Interleukin-10 TGFβ1 - Transforming growth factor β 1 BioCentury Staff Berkeley Lights Inc. New York University Langone Medical Center University of Maryland King's...

...changes and is personalized?” Ameet Nathwani, Sanofi   A publication in Diabetes Care from the University of Maryland...
...Pear Therapeutics Inc., Boston, Mass. Sanofi (Euronext:SAN; NASDAQ:SNY), Paris, France UCB S.A. (Euronext:UCB), Brussels, Belgium University of Maryland...

...at the Institute for Genome Sciences and a professor of microbiology and immunology at the University of Maryland...

...24, 2019 doi: 10.1371/journal.pgen.1008034 CONTACT: Thomas Hornyak, University of Maryland School of Medicine, Baltimore, Md. email: thornyak@som.umaryland.edu Hongjiang Li University of Maryland CD34 Neurology...

...exclusive option to license patent rights to mucin 1 (MUC1; CD227) decoy peptides from the University of Maryland...
...would explore using the IP to treat Pseudomonas , including in individuals with cystic fibrosis. University of Maryland...